This group had a significantly higher mean HbA1c, number of daily insulin injections, daily insulin dose, and SD around mean SMBG (indicator of glycemic variability) as compared to the group with type 2 diabetes. This evidence concerns the gene INS and type 2 diabetes mellitus.